Literature DB >> 32064490

Structurally characterized gallium-chrysin complexes with anticancer potential.

Eleftherios Halevas1, Barbara Mavroidi2, Orestis Antonoglou3, Antonios Hatzidimitriou3, Marina Sagnou2, Anastasia A Pantazaki4, George Litsardakis5, Maria Pelecanou2.   

Abstract

Chemotherapeutic metal-based compounds are effective anticancer agents; however, their cytotoxic profile and significant side effects limit their wide application. Natural products, especially flavonoids, are a prominent alternative source of anticancer agents that can be used as ligands for the generation of new bioactive complexes with metal ions of known biochemical and pharmacological activities. Herein, we present the synthesis and detailed structural and physicochemical characterizations of three novel complex assemblies of Ga(iii) with the flavonoid chrysin and the ancillary aromatic chelators 1,10-phenanthroline, 2,2'-bipyridine and imidazole. The complexes constitute the only crystallographically characterized structures having a metal core from the boron group elements and a flavonoid as the ligand. The in vitro biological evaluation of the three complexes in a series of cancer cell lines of different origin established their cytotoxicity and ROS generating potential. In particular, the Ga(iii)-chrysin-imidazole complex displayed the highest anticancer efficacy against all cancer cell lines with IC50 values in the low micromolar range (<1.18 μM), a result worth further investigation.

Entities:  

Year:  2020        PMID: 32064490     DOI: 10.1039/c9dt04540f

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  8 in total

1.  Biological evaluation of complexes of cyclopentadienyl M(CO)3+ (M = Re, 99mTc) with high blood-brain barrier penetration potential as brain cancer agents.

Authors:  B Mavroidi; A Kaminari; K Makrypidi; A Shegani; P Bouziotis; I Pirmettis; M Papadopoulos; M Sagnou; M Pelecanou
Journal:  Invest New Drugs       Date:  2022-01-13       Impact factor: 3.651

2.  Improving Anticancer Activity of Chrysin using Tumor Microenvironment pH-Responsive and Self-Assembled Nanoparticles.

Authors:  Ashok Kumar Jangid; Raghu Solanki; Sunita Patel; Kanakaraju Medicherla; Deep Pooja; Hitesh Kulhari
Journal:  ACS Omega       Date:  2022-04-25

3.  Evaluation of the Hemocompatibility and Anticancer Potential of Poly(ε-Caprolactone) and Poly(3-Hydroxybutyrate) Microcarriers with Encapsulated Chrysin.

Authors:  Eleftherios Halevas; Chrysoula Kokotidou; Elda Zaimai; Alexandra Moschona; Efstratios Lialiaris; Anna Mitraki; Theodore Lialiaris; Anastasia Pantazaki
Journal:  Pharmaceutics       Date:  2021-01-16       Impact factor: 6.321

Review 4.  Chrysin: Perspectives on Contemporary Status and Future Possibilities as Pro-Health Agent.

Authors:  Monika Stompor-Gorący; Agata Bajek-Bil; Maciej Machaczka
Journal:  Nutrients       Date:  2021-06-14       Impact factor: 5.717

Review 5.  Mesoporous Bioactive Glasses in Cancer Diagnosis and Therapy: Stimuli-Responsive, Toxicity, Immunogenicity, and Clinical Translation.

Authors:  Esmaeel Sharifi; Ashkan Bigham; Satar Yousefiasl; Maria Trovato; Matineh Ghomi; Yasaman Esmaeili; Pouria Samadi; Ali Zarrabi; Milad Ashrafizadeh; Shokrollah Sharifi; Rossella Sartorius; Farnaz Dabbagh Moghaddam; Aziz Maleki; Hao Song; Tarun Agarwal; Tapas Kumar Maiti; Nasser Nikfarjam; Colin Burvill; Virgilio Mattoli; Maria Grazia Raucci; Kai Zheng; Aldo R Boccaccini; Luigi Ambrosio; Pooyan Makvandi
Journal:  Adv Sci (Weinh)       Date:  2021-11-19       Impact factor: 16.806

6.  Rationale for Tailoring an Alternative Oncology Trial Using a Novel Gallium-Based Nanocomplex: Mechanistic Insights and Preclinical Challenges.

Authors:  Nihal Mostafa; Ahmed Salem; Somaya Z Mansour; Sawsan M El-Sonbaty; Fatma S M Moawed; Eman I Kandil
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

7.  Chromium Flavonoid Complexation in an Antioxidant Capacity Role.

Authors:  Sevasti Matsia; Olga Tsave; Antonios Hatzidimitriou; Athanasios Salifoglou
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208

Review 8.  Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives.

Authors:  Ebrahim Rahmani Moghadam; Hui Li Ang; Sholeh Etehad Asnaf; Amirhossein Zabolian; Hossein Saleki; Mohammad Yavari; Hossein Esmaeili; Ali Zarrabi; Milad Ashrafizadeh; Alan Prem Kumar
Journal:  Biomolecules       Date:  2020-09-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.